Schonfeld Strategic Advisors LLC Entera Bio Ltd. Call Options Transaction History
Schonfeld Strategic Advisors LLC
- $13.8 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENTX
# of Institutions
21Shares Held
5.34MCall Options Held
2.6KPut Options Held
100-
Knoll Capital Management, LLC Miami, FL3.88MShares$8.15 Million3.64% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT411KShares$863,2590.11% of portfolio
-
Ubs Group Ag143KShares$299,7680.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny61.2KShares$128,5200.0% of portfolio
-
Signature Estate & Investment Advisors LLC47.3KShares$99,3880.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $60.5M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...